Univ.-Prof. Mag. Dr. Harald Heinzl

Center for Medical Statistics, Informatics, and Intelligent Systems
Medical University of Vienna, Spitalgasse 23, A-1090 Wien; harald.heinzl@muv.ac.at


Vienna, April 17, 2019

List of Publications


[1]           F. Gamerith, G.J. Zlabinger, O. Scherak, G. Kolarz, M. Schemper, Harald Heinzl, J.E. Menzel (1993): Differences in anti-Fab antibodies in adult and late onset rheumatoid arthritis. Rheumatol. Int. 13: 107-112.

[2]           T.M.U. Wagner, A. Adler, P. Sevelda, I. Assmann, C.F. Knepflé, K. Czerwenka, Harald Heinzl, J.J. Ploem-Zaaijer (1994): Prognostic Significance of Cell DNA Content in Early-Stage Ovarian Cancer (Figo Stages I and II/A) by Means of Automatic Image Cytometry. Int. J. Cancer: 56, 167-172.

[3]           Joseph D. Nanobashvili, Georg Stacher, Ursula Windberger, Robert Dudczak, Christian Liegl, Vasili Gorgadze, Udo Losert, Harald Heinzl, Christoph Neumayer (1994): Regenerative potential of abdominal vagal nerves in rats. American Journal of Physiology 266: Gastrointestinal and Liver Physiology 29, G140-G146.

[4]           Ch. Kainz, H. Zeisler, P. Kohlberger, G. Gitsch, Harald Heinzl, G. Breitenecker, A. Reinthaller (1994): Prognostic Value of Cytokeratins and Carcinoembryonic Antigen Expression in Primary Surgically Treated Cervical Cancer. Anticancer Research 14: 667-672.

[5]           A. Gaiger, A. Neumeister, Harald Heinzl, I. Pabinger, S. Panzer (1994): HLA class-I and -II antigens in chronic idiopathic autoimmune thrombocytopenia. Annals of Hematology, Volume 68, Number 6, 299-302.

[6]           A.R. Rosenkranz, E. Templ, O. Traindl, Harald Heinzl, G.J. Zlabinger (1994): Reactive oxygen product formation by human neutrophils as an early marker for biocompatibility of dialysis membranes. Clin. Exp. Immunol., 98: 300-305.

[7]           Julius R. Lukas, Martin Aigner, Roland Blumer, Harald Heinzl, Robert Mayr (1994): Number and Distribution of Neuromuscular Spindles in Human Extraocular Muscles. Investigative Ophtalmology & Visual Science, Vol. 35, No. 13, 4317-4327.

[8]           Paul Speiser, Jutta Stolzlechner, Karin Haider, Harald Heinzl, Raimund Jakesz, Martin Pecherstorfer, Harald Rosen, Paul Sevelda, Robert Zeilliger (1994): pS2 Protein Status Fails to Be an Independent Prognostic Factor in an Average Breast Cancer Population. Anticancer Research 14: 2125-2130.

[9]           Ch. Kainz, G. Gitsch, C. Tempfer, Harald Heinzl, H. Koelbl, G. Breitecker, A. Reinthaller (1994): Vascular Space Invasion and Inflammatory Stromal Reaction as Prognostic Factors in Patients with Surgically Treated Cervical Cancer Stage IB to IIB. Anticancer Research 14: 2245-2248.

[10]        G. Gitsch, Ch. Kainz, A. Reinthaller, Harald Heinzl, G. Breitenecker (1995): Inzidenz zervikaler intraepithelialer Neoplasien 1980-1989. Österreichische Ärztezeitung 50/8, Seite 53-56.

[11]        Christian Kainz, Gerald Gitsch, Harald Heinzl, Gerhard Breitenecker (1995): Incidence of cervical smears indicating dysplasia among Austrian women during the 1980s. British Journal of Obstetrics and Gynaecology, Vol. 102, pp. 541-544.

[12]        C. Kainz, C. Tempfer, G. Gitsch, Harald Heinzl, A. Reinthaller, G. Breitenecker (1995): Influence of age and human papillomavirus-infection on reliability of cervical cytopathology. Archives of Gynecology and Obstetrics, 256, pp. 23-28.

[13]        Ch. Kainz, P. Kohlberger, G. Sliutz, C. Tempfer, Harald Heinzl, A. Reinthaller, G. Breitenecker, H. Koelbl (1995): Splice Variants of CD44 in Human Cervical Cancer Stage IB to IIB. Gynecologic Oncology 57, 383-387.

[14]        Regine Ahner, Christian Egarter, Herbert Kiss, Harald Heinzl, Robert Zeillinger, Christian Schatten, Anke Dormeier, Peter Husslein (1995): Fetal fibronectin as a selection criterion for induction of term labor. Am. J. Obstet. Gynecol., Volume 173, Number 5, 1513-1517. (My first name has been misspelIed by the journal.)

[15]        R. Windhager, K. Großschmidt, T. Tsuboyama, H. Siegl, Harald Heinzl, G. Seidl, H. Plenk, Jr. (1996): Recorticalization after Bifocal Internal Bone Transport in the Double-Plated Sheep Femur. Journal of Orthopaedic Research, Vol. 14, No. 1, 94-101.

[16]        K. Mayerhofer, J. Stolzlechner, S. Yildiz, K. Haider, Harald Heinzl, R. Jakesz, M. Pecherstorfer, H. Rosen, P. Sevelda, R. Zeillinger, P. Speiser (1996): Plasminogenaktivatorinhibitor 1 und Prognose beim Mammakarzinom. Geburtshilfe und Frauenheilkunde, 56. Jahrgang, Heft 1, 23-27.

[17]        R. Ladenstein, P.F. Ambros, Ch. Urban, I.M. Ambros, F.M. Fink, A. Zoubek, H. Grienberger, K. Schmitt, R. Kerbl, E. Horcher, G. Amann, G. Höfler, Harald Heinzl, H. Gadner, I. Mutz (1996): Wertigkeit prognostischer Faktoren in der österreichischen A-NB87 Neuroblastom Studie. Klinische Pädiatrie, Zeitschrift für Klinik und Praxis, Heft 4, Band 208, Seiten 210-220.

[18]        Petra D. Kohlberger, Andreas Obermair, Gerhard Sliutz, Harald Heinzl, Heinz Koelbl, Gerhard Breitenecker, Gerald Gitsch, Christian Kainz (1996): Quantitative Immunohistochemistry of Factor VIII-Related Antigen in Breast Carcinoma. A Comparison of Computer-Assisted Image Analysis With Established Counting Methods. American Journal of Clinical Pathology, Vol. 105, No. 6, pp. 705-710.

[19]        C. Tempfer, A. Lösch, Harald Heinzl, G. Häusler, E. Hanzal, H. Kölbl, G. Breitenecker, Ch. Kainz (1996): Prognostic Value of Immunohistochemically Detected CD44 Isoforms CD44v5, CD44v6 and CD44v7-8 in Human Breast Cancer. European Journal of Cancer, Vol. 32A, No. 11, Pages 2023-2025.

[20]        G. Haeusler, C. Tempfer, C. Kainz, Harald Heinzl(1996): Menstrual phase and timing of breast cancer surgery: statistical aspects. Letter to Editor, British Journal of Cancer 74, 1851-1852.

[21]        C. Tempfer, G. Haeusler, Harald Heinzl, R. Kolb, E. Hanzal, Ch. Kainz (1996): Menstrual phase and breast cancer surgery: influence on clinical outcome or pitfall of statistical analysis? Cancer Letters 110, 145-148.

[22]        Harald Heinzl, Alexandra Kaider, Gerhard Zlabinger (1996): Assessing Interactions of Binary Time-Dependent Covariates with Time in Cox Proportional Hazards Regression Models Using Cubic Spline Functions. Statistics in Medicine, Vol. 15, 2589-2601.

[23]        Harald Heinzl (1996): A Note on Testing Areas Under the Curve when Using Destructive Measurement Techniques. Journal of Pharmacokinetics and Biopharmaceutics (renamed as Journal of Pharmacokinetics and Pharmacodynamics in 2001), Vol. 24, No. 6, 651-655.

[24]        Harald Heinzl, Alexandra Kaider (1997): Ein SAS-Macro zur Einbindung kubischer Splinefunktionen ins proportionale Hazardsmodell von Cox. Konferenzbeiträge der 1. Konferenz der SAS-Benutzer in Forschung und Entwicklung (KSFE), Herausgeber: Rechenzentrum der Humboldt-Universität zu Berlin, Seiten 208-227.

[25]        Harald Heinzl, Alexandra Kaider (1997): Gaining more flexibility in Cox proportional hazards regression models with cubic spline functions. Computer Methods and Programs in Biomedicine 54, 201-208.

[26]        Harald Heinzl (1997): Some further remarks on testing areas under the curve when using destructive measurement techniques. American Statistical Association, 1997 Proceedings of the Biopharmaceutical Section, 129-131.

[27]        Jutta Fischer-Colbrie, Armin Witt, Harald Heinzl, Paul Speiser, Klaus Czerwenka, Paul Sevelda, Robert Zeillinger (1997): EGFR and Steroid Receptors in Ovarian Carcinoma: Comparison with Prognostic Parameters and Outcome of Patients. Anticancer Research 17, 613-620.

[28]        Sabine Walser, Robert Hruby, Ernst Hesse, Harald Heinzl, Hermann Mascher (1997): Preliminary Toxicokinetic Study with Different Crystal Forms of S (+)-Ibuprofen (Dexibuprofen) and R,S-Ibuprofen in Rats. Arzneimittel-Forschung/Drug Research 47 (I), 6, 750-754.

[29]        Nikolaus Klupp, Daniele Risser, Harald Heinzl, Georg Bauer (1997): Forensic Autopsies form 1984 to 1993 in Vienna, Austria. Journal of Forensic Sciences, Volume 42, Number 4, 675-677.

[30]        Petra D. Kohlberger, Dirk G. Kieback, Dagmar Bancher, Elmar Stickeler, Harald Heinzl, Gerald Gitsch, Gerhard Breitenecker, Christian Kainz (1997): Immunohistochemical Detection of CD44 Splice Variant Expression in Premalignant Lesions of the Cervix and Benign Cervical Epithelium. Gynecologic Oncology 66, 227-232.

[31]        H. Kotzmann, C. Abela, J. Heindl, M. Clodi, M. Riedl, U. Barnas, Harald Heinzl, B. Niederle, K. Geissler, W. Waldhäusl, A. Luger (1997): Effect of Successful Parathyroidectomy on Hemotopoietic Progenitor Cells and Parameters of Red Blood Cells in Patients with Primary Hyperparathyroidism. Horm. Metab. Res. 29, 387-392.

[32]        Regine Ahner, Petra Kub-Csizi, Harald Heinzl, Diana Bikas, Michaela Rabl, Peter Wagenbichler, Peter Husslein (1997): The fast-reacting fetal fibronectin test: A screening method for better prediction of the time of delivery. Am. J. Obstet. Gynecol., Volume 177, Number 6, pp. 1478-1482.

[33]        Martin Zehetmayer, Michael Georgopoulos, Irene Ruhswurm, Sabine Toma-Bständig, Klaus Kitz, Adolf Ertl, Harald Heinzl (1998): Marginal Dose and Tumor Regression after Stereotactic Irradiation for Uveal Melanoma. Kondziolka D. (ed.): Radiosurgery 1997. Radiosurgery. Basel, Karger, vol. 2, pp. 114-120.

[34]        René J. Wenzl, Harald Heinzl (1998): Localization of Matrix Metalloproteinase-2 in Uterine Endometrium and Ectopic Implants. Gynecologic and Obstetric Investigation 45: 253-257.

[35]        René Wenzl, Rainer Lehner, Andrea Holzer, Ursula Windberger, Harald Heinzl, Udo M. Losert (1998): Improved Laparoscopic Operating Techniques Using a Digital Enhancement Video System. The Journal of the American Association of Gynecologic Laparoscopists, Vol. 5, No. 2, 175-178.

[36]        C. Tempfer, H. Zeisler, Harald Heinzl, L. Hefler, P. Husslein, Ch. Kainz (1998): Influence of Acupuncture on Maternal Serum Levels of Interleukin-8, Prostaglandin F2alpha, and Beta-Endorphin: A Matched Pair Study. Obstetrics & Gynecology, Vol. 92, No. 2, 245-248.

[37]        Julius-Robert Lukas, Martin Aigner, Michaela Denk, Harald Heinzl, Martin Burian, Robert Mayr (1998): Carbocyanine Postmortem Neuronal Tracing: Influence of Different Parameters on Tracing Distance and Combination with Immunocytochemistry. The Journal of Histochemistry & Cytochemistry, Volume 46(8): 901-910.

[38]        U. Windberger, A. Bartholovitsch, G. Wollenek, Harald Heinzl, U. Losert (1998): Comparison of erythrocyte aggregation and whole blood viscosity of the fetal lamb (third quarter of gestation) and the adult sheep. Journal of Experimental Animal Science, 39: 34-42.

[39]        Lukas Hefler, Clemens Tempfer, Günther Häusler, Harald Heinzl, Christian Kainz (1998): Zytokeratintumormarker beim Ovarialkarzinom: Tissue Polypeptide Specific Antigen (TPS) und M3/M21. Wiener Klinische Wochenschrift, 110/18: 635-641.

[40]        C. Tempfer, L. Hefler, Harald Heinzl, A. Loesch, G. Gitsch, H. Rumpold, C. Kainz (1998): CYFRA 21-1 serum levels in women with adnexal masses and inflammatory diseases. British Journal of Cancer, 78 (8): 1108-1112.

[41]        Lukas Hefler, Clemens Tempfer, Harald Heinzl, Guenther Haeusler, Petra Steindl, Christian Schneeberger, Gerald Gitsch, Christian Kainz (1998): M3/M21 serum levels in women with adnexal masses and inflammatory diseases. Int. J. Cancer (Pred. Oncol.), 79: 434-438.

[42]        R. Lehner, R. Wenzl, Harald Heinzl, P. Husslein, P. Sevelda (1998): Influence of Delayed Staging Laparotomy After Laparoscopic Removal of Ovarian Masses Later Found Malignant. Obstetrics & Gynecology, Vol. 92, No. 6, 967-971.

[43]        Guenther Haeusler, Clemens Tempfer, Harald Heinzl, Christine Sam, Lukas Hefler, Engelbert Hanzal, Heinz Koelbl (1998): Value of urethral pressure profilometry in the female incontinent patient: a prospective trial with an 8-channel urethral catheter. Urology 52 (6): 1113-1117.

[44]        Martin Zehetmayer, Irene Ruhswurm, Michael Georgopoulos, Sabine Toma-Bständig, Klaus Kitz, Adolf Ertl, Karin Dieckmann, Günther Kren, Richard Pötter, Harald Heinzl (1998): Stereotaktische Bestrahlung uvealer Melanome: Erste Wiener Ergebnisse. Spektrum der Augenheilkunde 12/5: 171-174.

[45]        R. Pirker, G. Pohl, T. Stranzl, R.W. Suchomel, Harald Heinzl, K. Lechner, M. Filipits (1998): The Lung Resistance Protein (LRP) is an independent prognostic factor in acute myeloid leukemia. Proceedings of the 17th International Cancer Congress, Rio de Janeiro, Brazil, 24-28 August 1998, pp. 1337-1340.

[46]        Harald Heinzl (1998): Flexible Beschreibung der Wechselwirkung zwischen einer binären zeitabhängigen Kovariablen und der Zeit im Cox'schen Modell am Beispiel von Transplantationsdaten. Berichte der ÖGKC, Jahrgang 21, Heft 1, 31-36.

[47]        M. Schindl, K. Kerschan, A. Schindl, H. Schön, Harald Heinzl, L. Schindl (1999): Induction of complete wound healing in recalcitrant ulcers by low-intensity laser irradiation depends on ulcer cause and size. Photodermatology, Photoimmunology & Photomedicine 15: 18-21.

[48]        M. Sluga, R. Windhager, S. Lang, Harald Heinzl, S. Bielack, R. Kotz (1999): Local and Systemic Control After Ablative and Limb Sparing Surgery in Patients With Osteosarcoma. Clinical Orthopaedics and Related Research, Number 358, pp. 120-127.

[49]        C. Peters-Engl, A. Obermair, Harald Heinzl, P. Buxbaum, P. Sevelda, M. Medl (1999): CA 125 regression after two completed cycles of chemotherapy: lack of prediction for long-term survival in patients with advanced ovarian cancer. British Journal of Cancer 81(4), 662-666.

[50]        M. Filipits, T. Stranzl, G. Pohl, Harald Heinzl, U. Jäger, K. Geissler, C. Fonatsch, O.A. Haas, K. Lechner, R. Pirker (2000): Drug resistance factors in acute myeloid leukemia: a comparative analysis. Leukemia 14, 68-76.

[51]        Martin Zehetmayer, Klaus Kitz, Rupert Menapace, Adolf Ertl, Harald Heinzl, Irene Ruhswurm, Michael Georgopoulos, Karin Dieckmann, Richard Pötter (2000): Local tumor control and morbidity after one to three fractions of stereotactic external beam irradiation for uveal melanoma. Radiotherapy and Oncology 55, 135-144.

[52]        Peter Birner, Harald Heinzl, Monika Schindl, Jiri Pumprla, Peter Schnider (2000): Cardiac Autonomic Function in Patients Suffering from Primary Focal Hyperhidrosis. European Neurology 44, 112-116.

[53]        Martin Filipits, Ulrich Jaeger, Ingrid Simonitsch, Claudia Chizzali-Bonfadin, Harald Heinzl, Robert Pirker (2000): Clinical Relevance of the Lung Resistance Protein in Diffuse Large B-Cell Lymphomas. Clinical Cancer Research, Vol. 6, 3417-3423.

[54]        Janez Stare, Harald Heinzl, Frank Harrell (2000): On the Use of Buckley and James Least Squares Regression for Survival Data. New Approaches in Applied Statistics, Anuška Ferligoj and Andrej Mrvar (Editors), Metodološki zvezki, 16, Ljubljana: FDV, 125-134.

[55]        Harald Heinzl (2000): Dangers of Using 'Optimal' Cutpoints in the Evaluation of Cyclical Prognostic Factors. New Approaches in Applied Statistics, Anuška Ferligoj and Andrej Mrvar (Editors), Metodološki zvezki, 16, Ljubljana: FDV, 135-143.

[56]        Harald Heinzl (2000): Using SAS to calculate the Kent and O'Quigley measure of dependence for Cox proportional hazards regression model. Computer Methods and Programs in Biomedicine 63, 71-76.

[57]        Harald Heinzl, Axel Muttray, Detlev Jung, Ameneh Hergert, Dirk-Matthias Rose, Johannes Konietzko, Hans C. Hofmann, Christopher J. Portier, Lutz Edler (2000): Exploring possible dose-response relationships between 2,3,7,8-tetrachlorodibenzo-p-dioxin concentration and heart rate variability in humans. Organohalogen Compounds (ISBN 0-9703315-3-3), Vol. 48, 195-198.

[58]        Harald Heinzl, Clemens Tempfer (2001): A cautionary note on segmenting a cyclical covariate by minimum P-value search. Computational Statistics & Data Analysis 35, 451-461.

[59]        Martina Mittlböck, Harald Heinzl (2001): A note on R2 measures for Poisson and logistic regression models when both models are applicable. Journal of Clinical Epidemiology 54, 99-103.

[60]        Janez Stare, Frank E. Harrell Jr, Harald Heinzl (2001): BJ: an S-Plus program to fit linear regression models to censored data using the Buckley-James method. Computer Methods and Programs in Biomedicine 64, 45-52.

[61]        Walter Gall, Harald Heinzl, Peter Sachs (2001): Extracting a statistical data matrix from electronic patient records. Computer Methods and Programs in Biomedicine 66, 153-166. Erratum in Computer Methods and Programs in Biomedicine 69 (2002), 257-259.

[62]        A. Holzer, M. Greher, H. Hetz, H. Standhardt, A. Donner, Harald Heinzl, M. Zimpfer, U.M. Illievich (2001): Influence of aortic blood flow velocity on changes of middle cerebral artery blood flow velocity during isoflurane and sevoflurane anaesthesia. European Journal of Anaesthesiology 18, 238-244.

[63]        O. Findl, W. Drexler, R. Menapace, Harald Heinzl, C.K. Hitzenberger, A.F. Fercher (2001): Improved prediction of intraocular lens power using partial coherence interferometry. Journal of Cataract and Refractive Surgery 27(6), 861-867.

[64]        Florian Mittermayer, Petra Krepler, Martin Dominkus, Eva Schwameis, Maria Sluga, Harald Heinzl, Rainer Kotz (2001): Long-Term Followup of Uncemented Tumor Endoprostheses for the Lower Extremity. Clinical Orthopaedics and Related Research 388, 167-177.

[65]        F. Eichler, O. Ipsiroglu, T. Arif, C. Popow, Harald Heinzl, M. Urschitz, A. Pollak (2001): Position dependent changes of cerebral blood flow velocities in premature infants. European Journal of Pediatrics 160(10), 633-639.

[66]        M. Sluga, R. Windhager, S. Lang, Harald Heinzl, P. Krepler, F. Mittermayer, M. Dominkus, A. Zoubek, R. Kotz (2001): The role of surgery and resection margins in the treatment of Ewing’s sarcoma. Clinical Orthopaedics and Related Research 392, 394-399.

[67]        Lutz Edler, Axel Muttray, Detlev Jung, Dirk-Matthias Rose, Johannes Konietzko, Christopher J. Portier, Harald Heinzl (2001): Exploring possible dose-response relationships between exposure to PCDDs/Fs and acquired dyschromatopsia in humans. Organohalogen Compounds, Vol. 53, 309-312.

[68]        Lutz Edler, Harald Heinzl (2001): Toxicokinetic modeling for environmental health problems. International Conference on Statistical Challenges in Environmental Health Problems, August 30 – September 1, 2001, Fukuoka, Japan. Extended Abstracts, pp. 123-140.

[69]        Martina Mittlböck, Harald Heinzl (2002): Measures of explained variation in gamma regression models. Commun. Statist.-Simula., 31(1), 61-73.

[70]        Lutz Edler, Harald Heinzl (2002): Exploring the relationships between exposure to PCDDs/Fs and neurological health effects in humans. Organohalogen Compounds, Vol. 57, 415-418.

[71]        Florian Daxboeck, Karl Kircher, Robert Krause, Harald Heinzl, Christoph Wenisch, Gerold Stanek (2002): Effect of Age on Antibody Titer to Mycoplasma pneumoniae. Scand. J. Infect. Dis. 34: 577-579.

[72]        Petra Kohlberger, Verena Muller-Klingspor, Harald Heinzl, Andreas Obermair, Gerhard Breitenecker, Sepp Leodolter (2002): Prognostic Value of Laminin-5 in Serous Adenocarcinomas of the Ovary. Anticancer Research 22: 3541-3544.

[73]        Lutz Edler, Harald Heinzl, Detlev Jung, Axel Muttray (2002): Neurological health effects related to exposure to dioxins and furans – experiences from human studies in Germany. Proceedings of the Viet Nam – United States Scientific Conference on Human Health and Environmental Effects of Agent Orange/Dioxin. Part 2: Human Health Effects, pp. 704-725.

[74]        Harald Heinzl, Janez Stare, Martina Mittlböck (2002): A Measure of Dependence for the Stratified Cox Proportional Hazards Regression Model. Biometrical Journal, Volume 44, Number 6, pp. 671-682.

[75]        Harald Heinzl, Martina Mittlböck (2002): Adjusted R2 Measures for the Inverse Gaussian Regression Model. Computational Statistics, Volume 17, Issue 4, pp. 525-544.

[76]        Harald Heinzl, Lutz Edler (2002): Assessing uncertainty in a toxicokinetic model for human lifetime exposure to TCDD. Organohalogen Compounds, Vol. 59, 355-358.

[77]        Harald Heinzl, Lutz Edler (2003): Evaluating and assessing uncertainty of large-scaled statistical analyses exemplified at the Boehringer TCDD cohort. Proceedings of the Second workshop on Research Methodology (edited by: H.J. Adèr, G.J. Mellenbergh), RM 2003, VU University, Amsterdam, pp. 87-94.

[78]        Harald Heinzl, Martina Mittlböck (2003): Pseudo R-squared measures for Poisson regression models with over- or underdispersion. Computational Statistics & Data Analysis, 44:253-271.

[79]        Matthias G. Wirtitsch, Oliver Findl, Barbara Kiss, Vanessa Petternel, Harald Heinzl, Wolfgang Drexler (2003): Short-term effect of dorzolamide hydrochloride on central corneal thickness in humans with cornea guttata. Arch Ophthalmol, 121(5):621-625.

[80]        Monika Schindl, Sebastian F. Schoppmann, Thomas Ströbel, Harald Heinzl, Christina Leisser, Reinhard Horvat, Peter Birner (2003): Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors. Clinical Cancer Research, 9(2):779-785.

[81]        Karin Dieckmann, Richard Pötter, Johannes Hofmann, Harald Heinzl, Wolfgang Wagner, Günther Schellong; Pediatric Cooperative Hodgkin Disease Study Group of the GPOH (2003): Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90. Int J Radiation Oncology Biol Phys, 56(3):644-652.

[82]        Martina Mittlböck, Harald Heinzl (2003): Measures of explained variation for non-normal outcomes. Proceedings of the Second workshop on Research Methodology (edited by: H.J. Adèr, G.J. Mellenbergh), RM 2003, VU University, Amsterdam, pp. 47-50.

[83]        Lutz Edler, Harald Heinzl (2003): Toxicokinetic modeling for environmetric health problems. Environmetrics, 14/2:193-202.

[84]        C. Buchta, M. Felfernig, P. Höcker, M. Macher, G.F. Körmöczi, P. Quehenberger, Harald Heinzl, P. Knöbl (2004): Stability of coagulation factors in thawed, solvent/detergent-treated plasma during storage at 4 degrees C for 6 days. Vox Sanguinis, 87(3):182-186.

[85]        Maneli Mozaffarieh, Katharina Krepler, Harald Heinzl, Stefan Sacu, Andreas Wedrich (2004): Visual function, quality of life and patient satisfaction after ophthalmic surgery: a comparative study. Ophthalmologica, 218(1):26-30.

[86]        Erdem Ergun, Harald Heinzl, Michael Stur (2004): Prognostic factors influencing visual outcome of photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia. Am J Ophthalmol, 138(3):434-438.

[87]        Lutz Edler, Harald Heinzl, Martina Mittlböck (2004): Carrying-over Toxicokinetic Model Uncertainty into Cancer Risk Estimates: The TCDD Example. Organohalogen Compounds, Volume 66, pp. 3356-3362.

[88]        Harald Heinzl, M. Mittlboeck (2004): Design Aspects of a Computer Simulation Study for Assessing Uncertainty in Human Lifetime Toxicokinetic Models. COMPSTAT 2004, Proceedings in Computational Statistics (Edited by J. Antoch), Physica-Verlag Heidelberg (ISBN 3-7908-1554-3), pp. 199-211.

[89]        Harald Heinzl, Thomas Waldhör, Martina Mittlböck (2005): Careful use of pseudo R-squared measures in epidemiological studies. Statistics in Medicine, 24/18:2867-2872.

[90]        Harald Heinzl, Martina Mittlboeck, Lutz Edler (2005): On the role of ex post uncertainty assessment for risk management. International Journal of Risk Assessment & Management, 5/2-4:206-215.

[91]        Martina Mittlböck, Harald Heinzl (2005): Pseudo R-squared measures for generalized linear models. Proceedings of 1st European Workshop on the Assessment of Diagnostic Performance (Editors: E. Biganzoli, P. Boracchi, P. Duca and E. Ifeachor), Milan, Italy, pp. 71-80 (ISBN 88-8399-084-6).

[92]        Maneli Mozaffarieh, Harald Heinzl, Stefan Sacu, Andreas Wedrich (2005): Clinical outcomes of phacoemulsification cataract surgery in diabetes patients: visual function (VF-14), visual acuity and patient satisfaction. Acta Ophthalmologica Scandinavica, 83:176-183.

[93]        Christoph Buchta, Beatrice Hanslik-Schnabel, Roman Weigl, Jana List, Günther F. Körmöczi, Maria Macher, Harald Heinzl, Paul Höcker, Axel Wanivenhaus, Martin Kurz (2005): Quality of drainage blood: Survival of red cells after re-transfusion and content of free hemoglobin and potassium. International Journal of Surgery, 3:250-253.

[94]        VPK Nell, KP Machold, TA Stamm, G Eberl, H Heinzl, M Uffmann, JS Smolen, G Steiner (2005): Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Annals of the Rheumatic Diseases, 64:1731-1736.

[95]        F. Daxboeck, S. Mustafa, O. Assadian, Harald Heinzl, M. Stadler, A.M. Hirschl, W. Koller (2005): Accuracy of antibiotyping using standard antibiograms compared with 16S-23S ribosomal spacer PCR for diagnosis of MRSA. European Journal of Clinical Microbiology & Infectious Diseases, 24:640-642.

[96]        Hannes Rieger, Stefan Kuhle, Osman S. Ipsiroglu, Harald Heinzl, Christian N. Popow (2005): Effects of open vs. closed system endotracheal suctioning on cerebral blood flow velocities in mechanically ventilated extremely low birth weight infants. Journal of Perinatal Medicine, 33:435-441.

[97]        Rodrig Marculescu, Gottfried Sodeck, Hans Domanovits, Gerhard Hobusch, Markus Exner, Harald Heinzl, Kurt Huber, Christine Mannhalter, Erich Minar, Oswald Wagner, Martin Schillinger (2005): Interleukin-1 gene cluster variants and abdominal aortic aneurysms. Thrombosis and Haemostasis, 94/3:646-650.

[98]        Christoph Buchta, Claudia Bittner, Harald Heinzl, Paul Höcker, Maria Macher, Matthias Mayerhofer, Rainer Schmid, Christoph Seger, Markus Dettke (2005): Transfusion-related exposure to the plasticizer di(2-ethylhexyl)phthalate in patients receiving plateletpheresis concentrates. Transfusion, 45:798-802.

[99]        KA Borchhardt, H Heinzl, A Gessl, WH Hörl, K Kaserer, G Sunder-Plassmann (2006): Calcitonin concentrations in patients with chronic kidney disease and medullary thyroid carcinoma or c-cell hyperplasia. Kidney International, 70:2014-2020.

[100]      Maneli Mozaffarieh, Harald Heinzl, Stefan Sacu, Andreas Wedrich (2006): In-patient management and treatment satisfaction after intravitreous plasminogen activator injection. Graefe’s Archive for Clinical and Experimental Ophthalmology, 244:1421-1428.

[101]      C. Haberler, I. Slavc, T. Czech, E. Gelpi, Harald Heinzl, H. Budka, C. Urban, M. Scarpatetti, G. Ebetsberger-Dachs, C. Schindler, N. Jones, A. Klein-Franke, H. Maier, B. Jauk, A. Kiefer, J.A. Hainfellner (2006): Histopathological prognostic factors in medulloblastoma: High expression of survivin is related to unfavourable outcome. European Journal of Cancer, 42:2996-3003.

[102]      M Preusser, U Laggner, C Haberler, H Heinzl, H Budka, JA Hainfellner (2006): Comparative analysis of NeuN immunoreactivity in primary brain tumours: conclusions for rational use in diagnostic histopathology. Histopathology, 48:438-444.

[103]      Matthias Preusser, Harald Heinzl, Ellen Gelpi, Katharina Schonegger, Christine Haberler, Peter Birner, Christine Marosi, Monika Hegi, Thierry Gorlia, Johannes A. Hainfellner (2006): Histopathologic Assessment of Hot-Spot Microvessel Density and Vascular Patterns in Glioblastoma: Poor Observer Agreement Limits Clinical Utility as Prognostic Factors. Cancer, 107:162-170.

[104]      Christoph Buchta, Alexander Blacky, Gerda C. Leitner, Harald Heinzl, Günther F. Körmöczi, Maria Macher, Paul Höcker (2006): Surface disinfection of packed red blood cells with 70% ethanol. International Journal of Surgery, 4:118-121.

[105]      Thomas Waldhoer, Gerald Haidinger, Martin Wald, Harald Heinzl (2006): Non-random geographical distribution of infant mortality in Austria 1984-2002. Wiener Klinische Wochenschrift, 118/11-12:341-347.

[106]      Waldhoer T., Heinzl H. (2006): Spatial distribution of infant mortality based on district and community level in Austria. Conference Proceedings, Spatial Epidemiology Conference, 23-25 May 2006, London, UK, pp. 119-123.

[107]      M. Mittlböck, Harald Heinzl(2006): A simulation study comparing properties of heterogeneity measures in meta-analyses. Statistics in Medicine, 25/24:4321-4333.

[108]      Harald Heinzl, Martina Mittlböck, Lutz Edler (2007): On the translation of uncertainty from toxicokinetic to toxicodynamic models – The TCDD example. Chemosphere, 67/9:S365-S374.

[109]      Harald Heinzl, Martina Mittlböck (2007): Eine Einführung zu chirurgischen Lernkurvenstudien aus Sicht der medizinischen Statistik und Dokumentation. Forum der Medizin_Dokumentation und Medizin_Informatik, 9/1:30-33.

[110]      Harald Heinzl, Axel Benner, Carina Ittrich, Martina Mittlböck (2007): Proposals for Sample Size Calculation Programs. Methods of Information in Medicine, Vol. 46, Issue 6, pp. 655-661.

[111]      Andrea Michalek-Sauberer, Harald Heinzl, Sabine M. Sator-Katzenschlager, Gabriel Monov, Erich Knolle, Hans Georg Kress (2007): Perioperative Auricular Electroacupuncture Has no Effect on Pain and Analgesic Consumption After Third Molar Tooth Extraction. Anesthesia & Analgesia, 104/3:542-547.

[112]      Georg Rainer, Katharina Emanuela Schmid, Oliver Findl, Stefan Sacu, Barbara Kiss, Harald Heinzl, Rupert Menapace (2007): Natural Course of Intraocular Pressure after Cataract Surgery with Sodium Hyaluronate 1% versus Hydroxypropylmethylcellulose 2%. Ophthalmology, 114:1089-1093.

[113]      D. Doberer, M. Gschwandtner, W. Mosgoeller, C. Bieglmayer, Harald Heinzl, V. Petkov (2007): Pulmonary and systemic effects of inhaled PACAP38 in healthy male subjects. European Journal of Clinical Investigation, 37/8:665-672.

[114]      Matthias G. Wirtitsch, Oliver Findl, Harald Heinzl, Wolfgang Drexler (2007): Effect of Dorzolamide Hydrochloride on Central Corneal Thickness in Humans With Cornea Guttata. Archives of Ophthalmology, Vol. 125, No. 10, pp. 1345-1350.

[115]      Matthias G. Wirtitsch, Rupert Menapace, Michael Georgopoulos, Georg Rainer, Wolf Buehl, Harald Heinzl (2007): Intraocular pressure rise after primary posterior continuous curvilinear capsulorhexis with a fixed dorzolamide-timolol combination: Randomized safety study with intraindividual comparison using an angulated and a nonangulated intraocular lens. Journal of Cataract & Refractive Surgery, Vol. 33, Issue 10, pp. 1754-1759.

[116]      Andrea Michalek-Sauberer, Sibylle A. Kozek-Langenecker, Harald Heinzl, Engelbert Deusch, Astrid Chiari (2008): Median Effective Local Anesthetic Doses of Plain Bupivacaine and Ropivacaine for Spinal Anesthesia Administered Via a Spinal Catheter for Brachytherapy of the Lower Abdomen. Regional Anesthesia and Pain Medicine, Vol. 33, No. 1, pp. 4-9.

[117]      Wolf Buehl, Harald Heinzl, Martina Mittlboeck, Oliver Findl (2008): Statistical problems caused by missing data resulting from neodymium:YAG laser capsulotomies in long-term posterior capsule opacification studies: Problem identification and possible solutions. Journal of Cataract & Refractive Surgery, Vol. 34, Issue 2, pp. 268-273.

[118]      Thomas Waldhoer, Martin Wald, Harald Heinzl (2008): Analysis of the spatial distribution of infant mortality by cause of death in Austria in 1984 to 2006. International Journal of Health Geographics, 7:21 (9 pages).

[119]      Ellen Gelpi, Harald Heinzl, Romana Höftberger, Ursula Unterberger, Thomas Ströbel, Till Voigtländer, Edita Drobner, Christa Jarius, Susanna Lang, Thomas Waldhör, Hanno Bernheimer, Herbert Budka (2008): Creutzfeldt-Jakob Disease in Austria: An Autopsy-Controlled Study. Neuroepidemiology, Vol. 30, No. 4, pp. 215-221.

[120]      M Preusser, H Heinzl, E Gelpi, R Höftberger, I Fischer, I Pipp, I Milenkovic, A Wöhrer, F Popovici, S Wolfsberger, J A Hainfellner (2008): Ki67 index in intracranial ependymoma: a promising histopathological candidate biomarker. Histopathology, Vol. 53, Issue 1, pp. 39-47.

[121]      Matthias Preusser, Robert Charles Janzer, Jörg Felsenberg, Guido Reifenberger, Marie-France Hamou, Annie-Claire Diserens, Roger Stupp, Thierry Gorlia, Christine Marosi, Harald Heinzl, Johannes A Hainfellner, Monika Hegi (2008): Anti-O6-Methylguanine-Methyltransferase (MGMT) Immunohistochemistry in Glioblastoma Multiforme: Observer Variability and Lack of Association with Patient Survival Impede Its Use as Clinical Biomarker. Brain Pathology, Vol. 18, Issue 4, pp. 520-532.

[122]      Kyra A. Borchhardt, Harald Heinzl, Elisabeth Mayerwöger, Walter H. Hörl, Martin Haas, Gere Sunder-Plassmann (2008): Cinacalcet Increases Calcium Excretion in Hypercalcemic Hyperparathyroidism After Kidney Transplantation. Transplantation, Vol. 86, Number 7, pp. 919-924.

[123]      Harald Heinzl, Martina Mittlböck, Lutz Edler (2008): Technical uncertainty in the back-calculation of occupational exposure to dioxins. Statistics in Medicine, Vol. 27, Issue 12, pp. 2214-2233.

[124]      Harald Heinzl (2009): Kaplan-Meier-Kurven und die Hazard Ratio. krebs:hilfe!, Heft 2, Seiten X-XI.

[125]      Maneli Mozaffarieh, Harald Heinzl, Stefan Sacu, Andreas Wedrich (2009): Second Eye Cataract Surgery in the Diabetes Patient? Quality of Life Gains and Speed of Visual and Functional Rehabilitation. Ophthalmic Research, Vol. 41, pp. 2-8.

[126]      K. Schoenegger, S. Oberndorfer, B. Wuschitz, W. Struhal, J. Hainfellner, D. Prayer, Harald Heinzl, H. Lahrmann, C. Marosi and W. Grisold (2009): Peritumoral edema on MRI at initial diagnosis: an independent prognostic factor for glioblastoma? European Journal of Neurology, Vol. 16, pp. 874-878.

[127]      P. Wexberg, W. Sperker, N.G. Morgenthaler, Harald Heinzl, C. Adlbrecht, C. Plass, H.D. Glogar, I.M. Lang, T. Neunteufl (2009): Inhomogeneous vasomotor effects of moderate selective and non-selective endothelin-receptor blockade in stable coronary artery disease. Heart, Vol. 95, pp. 1258-1264.

[128]      Martin Filipits, Margaretha Rudas, Harald Heinzl, Raimund Jakesz, Ernst Kubista, Sigurd Lax, Walter Schippinger, Otto Dietze, Richard Greil, Wolfgang Stiglbauer, Werner Kwasny, Alexander Nader, Michael Stierer, and Michael F.X. Gnant for the Austrian Breast and Colorectal Cancer Study Group (2009): Low p27 Expression Predicts Early Relapse and Death in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients Receiving Adjuvant Tamoxifen Therapy. Clinical Cancer Research, Vol. 15, Number 18, pp. 5888-5894.

[129]      Adelheid Wöhrer, Thomas Waldhör, Harald Heinzl, Monika Hackl, Johann Feichtinger, Ulrike Gruber-Mösenbacher, Andreas Kiefer, Hans Maier, Reinhard Motz, Angelika Reiner-Concin, Bernd Richling, Carmen Idriceanu, Michael Scarpatetti, Roland Sedivy, Hans-Christian Bankl, Wolfgang Stiglbauer, Matthias Preusser, Karl Rössler, Johannes Andreas Hainfellner (2009): The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry. Journal of Neuro-Oncology, Vol. 95, Number 3, pp. 401-411.

[130]      V. Nell-Duxneuner, K. Machold, T. Stamm, G. Eberl, Harald Heinzl, E. Hoefler, J.S. Smolen, G. Steiner (2010): Autoantibody profiling in patients with very early rheumatoid arthritis: a follow-up study. Annals of the Rheumatic Diseases, Vol. 69, Issue 1, pp. 169-174.

[131]      Wolfgang Gartner, Aysegül Ilhan, Dashurie Neziri, Wolfgang Base, Michael Weissel, Adelheid Wöhrer, Harald Heinzl, Thomas Waldhör, Ludwig Wagner, and Matthias Preusser (2010): Elevated blood markers 1 year before manifestation of malignant glioma. Neuro-Oncology 12(9):1004-1008.

[132]      Adelheid Woehrer, Irene Slavc, Thomas Waldhoer, Harald Heinzl, Nadine Zielonke, Thomas Czech, Martin Benesch, Johannes A. Hainfellner, and Christina Haberler on behalf of the Austrian Brain Tumor Registry (2010): Incidence of Atypical Teratoid/Rhabdoid Tumors in Children. A Population-Based Study by the Austrian Brain Tumor Registry, 1996–2006. Cancer 116(24):5725-5732.

[133]      D Doberer, A Haschemi, M Andreas, T-C Zapf, B Clive, M Jeitler, H Heinzl, O Wagner, M Wolzt and M Bilban (2010): Haem arginate infusion stimulates haem oxygenase-1 expression in healthy subjects. British Journal of Pharmacology 161(8):1751-1762.

[134]      J.A. Hainfellner and Harald Heinzl (2010): Neuropathological biomarker candidates in brain tumors: key issues for translational efficiency. Clinical Neuropathology, Vol. 29, No. 1, pp. 41-54.

[135]      Thomas Waldhoer and Harald Heinzl (2011): Combining difference and equivalence test results in spatial maps. International Journal of Health Geographics, 10:3 (10 pages).

[136]      Harald Heinzl and Thomas Waldhoer (2011): Difference and equivalence tests in spatial maps. Proceedings of the 4th International Conference on Risk Analysis-ICRA 4, edited by Alex Karagrigoriou, University of Cyprus, Nicosia, pp. 151-156 (ISBN: 978-9963-9965-0-6).

[137]      Manuela Schmidinger, Ursula M. Vogl, Marija Bojic, Wolfgang Lamm, Harald Heinzl, Andrea Haitel, Martin Clodi, Gero Kramer, and Christoph C. Zielinski (2011): Hypothyroidism in Patients With Renal Cell Carcinoma. Blessing or Curse? Cancer, Vol. 117, Issue 3, pp. 534-544.

[138]      Johannes J. Kovarik, Wolfgang Tillinger, Johannes Hofer, Markus A. Hölzl, Harald Heinzl, Marcus D. Saemann and Gerhard J. Zlabinger (2011): Impaired anti-inflammatory efficacy of n-butyrate in patients with IBD. European Journal of Clinical Investigation, Vol. 41, Issue 3, pp. 291-298.

[139]      Matthias Preusser, Katarzyna Elandt, Ilse Schwarzinger, Christine Marosi, Harald Heinzl (2011): Immature and absolute platelet count changes and thrombocytopenia in malignant glioma. European Journal of Clinical Investigation, Vol. 41, Issue 5, pp. 539-545.

[140]      D. Bonderman, P. Wexberg, A.M. Martischnig, H. Heinzl, M-B. Lang, R. Sadushi, N. Skoro-Sajer, I.M. Lang (2011): A non-invasive algorithm to exclude precapillary pulmonary hypertension. European Respiratory Journal, Vol. 37, Issue 5, pp. 1096-1103.

[141]      Thomas Waldhoer and Harald Heinzl (2011): Choosing the wrong alternative hypothesis in spatial maps. Proceedings of the 4th International Conference on Risk Analysis-ICRA 4, edited by Alex Karagrigoriou, University of Cyprus, Nicosia, pp. 319-321 (ISBN: 978-9963-9965-0-6).

[142]      Thomas Waldhoer and Harald Heinzl (2011): Accepting the Wrong Alternative Hypothesis in Spatial Maps. Numerical Analysis and Applied Mathematics ICNAAM 2011, AIP Conference Proceedings 1389, pp. 430-432 (ISBN: 978-0-7354-0956-9).

[143]      Anna Sophie Berghoff, Harald Stefanits, Harald Heinzl and Matthias Preusser (2012): Clinical Neuropathology Practice News 4-2012: levels of evidence for brain tumor biomarkers. Clinical Neuropathology, 31(4):206-209.

[144]      Matthias Preusser, Romana Hoeftberger, Adelheid Woehrer, Ellen Gelpi, Mathilde Kouwenhoven, Johan M Kros, Marc Sanson, Ahmed Idbaih, Alba A Brandes, Harald Heinzl, Thierry Gorlia, Johannes A Hainfellner, Martin van den Bent (2012): Prognostic value of Ki67 index in anaplastic oligodendroglial tumours – a translational study of the European Organization for Research and Treatment of Cancer Brain Tumor Group. Histopathology 60(6):885–894.

[145]      Sebastian F. Schoppmann, Anna Berghoff, Carina Dinhof, Raimund Jakesz, Michael Gnant, Peter Dubsky, Bettina Jesch, Harald Heinzl, Peter Birner (2012): Podoplanin-expressing cancer-associated fibroblasts are associated with poor prognosis in invasive breast cancer. Breast Cancer Research and Treatment 134(1):237–244.

[146]      Elisabeth Puchhammer-Stöckl, Stephan W. Aberle, Harald Heinzl (2012): Association of age and gender with alphaherpesvirus infections of the central nervous system in the immunocompetent host. Journal of Clinical Virology 53(4):356-359.

[147]      Matthias Preusser, Gerhard Fülöp, Anna Sophie Berghoff, Harald Heinzl, Guenther G. Steger, Richard Greil, Christoph C. Zielinski, Rupert Bartsch (2012): Influence of the American ODAC Statement upon Austrian Prescription Practice of Bevacizumab in Metastatic Breast Cancer. The Oncologist 17(7):e13-e17.

[148]      Anna Probst, Susanne Humpeler, Harald Heinzl, Gerhard Blasche, Cem Ekmekcioglu (2012): Short-term effect of macronutrient composition and glycemic index of a yoghurt breakfast on satiety and mood in healthy young men. Forschende Komplementärmedizin 19(5):247-251.

[149]      Diana Bonderman, Paul Wexberg, Harald Heinzl, Irene M. Lang (2012): Non-invasive algorithms for the diagnosis of pulmonary hypertension. Thrombosis and Haemostasis 108(6):1037-1041.

[150]      Harald Heinzl, Philipp Bloching (2012): Quantitative assessment of scientific quality. Numerical Analysis and Applied Mathematics ICNAAM 2012, AIP Conference Proceedings 1479, pp. 424-426 (ISBN: 978-0-7354-1091-6).

[151]      Harald Heinzl, Thomas Waldhoer (2012): Relevance of the type III error in epidemiological maps. International Journal of Health Geographics, 11:34.

[152]      Philipp A. Bloching, Harald Heinzl (2013): Assessing the scientific relevance of a single publication over time. South African Journal of Science 109(9/10):93-94.

[153]      Aysegul Ilhan-Mutlu, Ludwig Wagner, Georg Widhalm, Adelheid Wöhrer, Sophie Bartsch, Thomas Czech, Harald Heinzl, Fritz Leutmezer, Daniela Prayer, Christine Marosi, Wolfgang Base, Matthias Preusser (2013): Exploratory investigation of eight circulating plasma markers in brain tumor patients. Neurosurgical Review 36(1):45-55; discussion 55-56.

[154]      Wolfgang Sieghart, Florian Hucke, Matthias Pinter, Ivo Graziadei, Wolfgang Vogel, Christian Müller, Harald Heinzl, Michael Trauner, Markus Peck-Radosavljevic (2013): The ART of decision making: retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma. Hepatology 57(6):2261-2273.

[155]      Gabor G. Kovacs, Ivan Milenkovic, Adelheid Wöhrer, Romana Höftberger, Ellen Gelpi, Christine Haberler, Selma Hönigschnabl, Angelika Reiner-Concin, Harald Heinzl, Susanne Jungwirth, Wolfgang Krampla, Peter Fischer, Herbert Budka (2013): Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series. Acta Neuropathologica 126(3):365-384.

[156]      Anna S. Berghoff, Harald Stefanits, Adelheid Woehrer, Harald Heinzl, Matthias Preusser, Johannes A. Hainfellner (2013): Clinical Neuropathology Practice Guide 3-2013: levels of evidence and clinical utility of prognostic and predictive candidate brain tumor biomarkers. Clinical Neuropathology 32(3):148-158.

[157]      Florian Hucke, Wolfgang Sieghart, Matthias Pinter, Ivo Graziadei, Wolfgang Vogel, Christian Müller, Harald Heinzl, Fredrik Waneck, Michael Trauner, Markus Peck-Radosavljevic (2014): The ART-strategy: Sequential assessment of the ART score predicts outcome of patients with hepatocellular carcinoma re-treated with TACE. Journal of Hepatology 60(1):118-126.

[158]      J Gerry Coghlan, Christopher P Denton, Ekkehard Grünig, Diana Bonderman, Oliver Distler, Dinesh Khanna, Ulf Müller-Ladner, Janet E Pope, Madelon C Vonk, Martin Doelberg, Harbajan Chadha-Boreham, Harald Heinzl, Daniel M Rosenberg, Vallerie V McLaughlin, James R Seibold; on behalf of the DETECT study group (2014): Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Annals of the Rheumatic Diseases 73(7):1340-1349.

[159]      A. S. Berghoff, A. Ilhan-Mutlu, A. Wöhrer, M. Hackl, G. Widhalm, J. A. Hainfellner, K. Dieckmann, T. Melchardt, B. Dome, Harald Heinzl, P. Birner, M. Preusser (2014): Prognostic significance of Ki67 proliferation index, HIF1 alpha index and microvascular density in patients with non-small cell lung cancer brain metastases. Strahlentherapie und Onkologie 190(7):676-685.

[160]      F. Hucke, M. Pinter, I. Graziadei, S. Bota, W. Vogel, C. Müller, Harald Heinzl, F. Waneck, M. Trauner, M. Peck-Radosavljevic, W. Sieghart (2014): How to STATE suitability and START transarterial chemoembolization in patients with intermediate stage hepatocellular carcinoma. Journal of Hepatology 61(6):1287-1296.

[161]      M. Bienkowski, A. S. Berghoff, C. Marosi, A. Wöhrer, Harald Heinzl, J. A. Hainfellner, M. Preusser (2015): Clinical Neuropathology practice guide 5-2015: MGMT methylation pyrosequencing in glioblastoma: unresolved issues and open questions. Clinical Neuropathology 34(5):250-257.

[162]      A. Araki, M. Chocholous, J. Gojo, C. Dorfer, T. Czech, Harald Heinzl, K. Dieckmann, I. M. Ambros, P. F. Ambros, I. Slavc, C. Haberler (2016): Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma. Acta Neuropathologica Communications 4(1):88 (10 pages).

[163]      A. S. Berghoff, E. Fuchs, G. Ricken, B. Mlecnik, G. Bindea, T. Spanberger, M. Hackl, G. Widhalm, K. Dieckmann, D. Prayer, A. Bilocq, Harald Heinzl, C. Zielinski, R. Bartsch, P. Birner, J. Galon, M. Preusser (2016): Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases. Oncoimmunology 5(1):e1057388 (8 pages).

[164]      Harald Heinzl, M. Mittlboeck (2017): Assessing a hypothesis test for the difference between two quantiles from independent populations. Communications in Statistics: Simulation and Computation 46(5):3540-3552.

[165]      Thomas Waldhoer, Harald Heinzl (2017): Exploring the possible relationship between ambient heat and sudden infant death with data from Vienna, Austria. PLoS ONE 12(9): e0184312.

[166]      Ulrike Pötschger, Harald Heinzl, Maria Grazia Valsecchi and Martina Mittlböck (2018): Assessing the effect of a partly unobserved, exogenous, binary time-dependent covariate on survival probabilities using generalised pseudo-values. BMC Medical Research Methodology 18:14 (11 pages).

[167]      Harald Heinzl, Martina Mittlboeck (2018): Visualizing the quantile survival time difference curve. Journal of Evaluation in Clinical Practice 24(4):708-712.

[168]      Harald Heinzl, Martina Mittlboeck (2018): Contribution to the discussion of “When should meta-analysis avoid making hidden normality assumptions?” Biometrical Journal 60(6):1085-1086.

[169]      Georg Duftschmid, Christoph Rinner, Simone Katja Sauter, Gottfried Endel, Peter Klimek, Christoph Mitsch, Harald Heinzl (2019): Patient-Sharing Relations in the Treatment of Diabetes and Their Implications for Health Information Exchange: Claims-Based Analysis. JMIR Medical Informatics 7(2):e12172.

[170]      Hans-Peter Hutter, Thomas Waldhoer, Katja Müller, Monika Hackl, Lisbeth Weitensfelder, Harald Heinzl (2019): Cancer incidence in an Austrian alpine valley 1983–2012. Wiener klinische Wochenschrift (https://doi.org/10.1007/s00508-019-1476-7).

Book Chapters:

[bc1]      T. Kapitany, Harald Heinzl, G. Sonneck (1995): Effekte gezielter und ungezielter Medienaktionen auf die Inanspruchnahme des Kriseninterventionszentrums. In: Krisenintervention und Suizidverhütung. Ein Leitfaden für den Umgang mit Menschen in Krisen. Herausgegeben von G. Sonneck. Mit einem Geleitwort von E. Ringel †. Facultas Universitäts­verlag: Wien, 3. verbesserte und erweiterte Auflage, Seiten 242-244.

[bc2]      Lutz Edler, Annette Kopp-Schneider, Harald Heinzl (2005): Dose-Response Modeling. Chapter 13 in: Recent Advances in Quantitative Methods in Cancer and Human Health Risk Assessment. Edited by Lutz Edler and Christos P. Kitsos. John Wiley & Sons: Chichester, pp. 211-237.

Book Reviews:

[br1]       Harald Heinzl (2001): Book review of “Analysis of multivariate survival data” by Philip Hougaard, 2000. Zentralblatt MATH, Zbl 0962.62096.

[br2]       Harald Heinzl (2009): Book review of “The statistical analysis of recurrent events” by Richard J. Cook and Jerald F. Lawless, 2007. Zentralblatt MATH, Zbl 1159.62061.

[br3]       Harald Heinzl (2010): Book review of “Survival analysis for epidemiologic and medical research. A practical guide” by Steve Selvin, 2008. Zentralblatt MATH, Zbl 1182.62208.

[br4]       Harald Heinzl (2013): Book review of “Principles of Uncertainty” by Joseph B. Kadane, 2011. Biometrical Journal 55(4):640-641.

[br5]       Harald Heinzl (2014): Book review of “Bayesian adaptive methods for clinical trials” by Scott M. Berry, Bradley P. Carlin, J. Jack Lee, and Peter Müller, 2011. Zentralblatt MATH, Zbl 1306.62005.